Iovance Biotherapeutics, Inc. stock jumps 130% in 2026 but RSI screams overbought

Iovance Biotherapeutics, Inc. stock has become a standout momentum story in 2026, closing at $6.98 on volume of roughly 17.4 million shares. With the stock up more than 130% this year, the focus shifts from trend direction to how far the rally can stretch before pausing.

Key takeaways

• Iovance Biotherapeutics, Inc. stock closed at $6.98, with a session high of $7.00 and a low of $6.36, on volume of about 17.4 million shares.
• The stock is up more than 130% in 2026, with bullish daily EMAs: EMA20 at 5.56, EMA50 at 4.87, and EMA200 at 3.73.
• Daily RSI14 reads 73.02, while the 1-hour RSI14 is 71.96 and the 15-minute RSI14 is 81.78, signaling overbought conditions.
• Daily resistance sits at R1 7.20, with support at S1 6.56 and the daily pivot at 6.78.
• Q2 2026 earnings highlighted record Amtagvi revenue and strong gross margins.

Daily Momentum for Iovance Biotherapeutics, Inc. Stock: Strong Trend, Overheated RSI

The daily trend in Iovance Biotherapeutics, Inc. stock remains bullish. Price holds above the EMA20 at 5.56, the EMA50 at 4.87, and the EMA200 at 3.73. This bullish stack keeps every layer of trend support rising beneath the current price. The daily regime reading is also flagged as bullish.

… Continue reading the full article at the original source below.